These awards will help pioneer and accelerate novel drug development for the treatment of Parkinson’s, providing researchers the opportunity to plug essential gaps in existing datasets to get their projects/compounds ready to enter full scale drug discovery with an industry partner or the Parkinson’s Virtual Biotech. We are looking for projects that will have a clear focus on translational drug development to make a difference to those affected by Parkinson’s.
The deadline for pre-proposal applications is Thursday 10 February 2022, by 4 pm. The deadline for full applications is Thursday 24 March 2022, by 4 pm. Please email [email protected] for a copy of the pre-proposal application.
DURATION & VALUE
The duration of a grant is up to a maximum of 12 months.
There is no minimum value and the maximum award amount is £50,000.
Grants are tenable only at a UK university, NHS Trust or small start-up biotech companies.
Principal applicants should hold employment contracts that extend beyond the period of the grant.
Co-applicants and collaborators may be based at institutions outside the UK or biotech companies.
Apply for a Drug Accelerator Award
Get updates on grants
Be the first to find out about funding, events, news and opportunities in the world of research by signing up to Synapse - our enewsletter for the Parkinson's research community.